Atul Suri

Atul Suri, Vice President and SBU Head at Alembic Pharm. Ltd., dives deep into the critical role of Key Opinion Leaders (KOLs) in the pharmaceutical industry. He discusses how KOLs bridge the gap between research and clinical practice, enhancing patient outcomes and driving innovation. Atul emphasizes strategies for effective KOL engagement, the shift from traditional to digital knowledge sharing, and the importance of maintaining ongoing relationships with these influencers to evolve patient care. Insightful and essential for anyone in pharma!